Original articleSafety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Abbreviations and Acronyms
Cited by (0)
Financial Disclosure(s): The authors have made the following disclosures: E.B.S.: Steering committee – AbbVie; Consultant – AbbVie, Gilead, Inotek, Mallinckrodt, XOMA, Santen; Research support – AbbVie, Aldeyra, Bristol-Myers Squibb, EyeGate, Clearside, Genentech, pSivida.
A.A.: Advisory boards – AbbVie, Santen, Allergan.
A.P.B.: Advisory boards and consultant – AbbVie.
E.F.: Advisory boards and consultant – AbbVie, Alcon, Allergan.
H.G., A.S., T.K., and A.D.D.: Advisory boards – AbbVie.
G.J.J., M.Kramer, and C.M.: Consultants – AbbVie.
L.L.L.: Advisory boards and consultant – AbbVie, Bayer, Allergan.
Q.D.N.: Scientific advisory boards – AbbVie, Santen, XOMA, Bausch & Lomb; Chairs the steering committee for the VISUAL studies.
J.V.C.: Research support – Novartis; Personal fees – Novartis, Bayer, AbbVie, MSD, DORC, Allergan, Santen, Zeiss; Nonfinancial support – Novartis, Bayer, AbbVie, DORC, Allergan.
A.P.S. and J.L.: Employees – AbbVie Inc.
S.T.: Employee – AbbVie Inc at the time of the study.
M.Kron and A.C.: Employees – AbbVie Deutschland GmbH & Co KG.
S.P.: Employee – AbbVie Ltd UK.
M.E.J.V.V.: Lecturer – AbbVie Netherlands, Novartis Netherlands, Bayer Netherlands; Travel reimbursements – Allergan Europe.
A.T.V.: Consultant – ACIONT.
M.Z.: Scientific advisory boards – AbbVie, Santen.
Sponsored by AbbVie Inc (North Chicago, IL). The sponsor participated in study design and conduct; data management, analysis, and interpretation; and manuscript preparation, review, and approval.
Medical writing support was provided by Heather D. Starkey, PhD, and Natalia Zhukovskaya, PhD, of Complete Publication Solutions, LLC (North Wales, PA), and was funded by AbbVie Inc.
HUMAN SUBJECTS: Human subjects were part of this study protocol. No animal subjects were used in this study. The study complied with the ethical principles of the Declaration of Helsinki and the International Conference on Harmonisation Guidelines for Good Clinical Practice; sites in the United States conformed to the requirements of the Health Insurance Portability and Accountability Act. All patients signed a statement of informed consent before enrollment, and all procedures were reviewed and approved by appropriate institutional review boards or ethics committees before study initiation.
Author Contributions:
Manuscript preparation: Suhler, Adán, Brézin, Fortin, Goto, Jaffe, Kaburaki, Kramer, Lim, Muccioli, Nguyen, Van Calster, Cimino, Kron, Song, Liu, Pathai, Camez, Schlaen, van Velthoven, Vitale, Zierhut, Tari, Dick
Data collection: Suhler, Adán, Brézin, Fortin, Goto, Jaffe, Kaburaki, Kramer, Lim, Muccioli, Nguyen, Van Calster, Cimino, Schlaen, van Velthoven, Vitale, Zierhut, Dick
Analysis and interpretation: Suhler, Adán, Brézin, Fortin, Goto, Jaffe, Kaburaki, Kramer, Lim, Muccioli, Nguyen, Van Calster, Cimino, Kron, Song, Liu, Pathai, Camez, Schlaen, van Velthoven, Vitale, Zierhut, Tari, Dick
Obtained funding: N/A
Overall responsibility: Suhler, Adán, Brézin, Fortin, Goto, Jaffe, Kaburaki, Kramer, Lim, Muccioli, Nguyen, Van Calster, Cimino, Kron, Song, Liu, Pathai, Camez, Schlaen, van Velthoven, Vitale, Zierhut, Tari, Dick
Supplemental material available at www.aaojournal.org.